GlassScriptPhysician profile
J B Astik
NPI 1912901299
$661.99
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $99.89 · 2021: $194 · 2022: $40.71.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $173.68 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $98.16 | 2019-2020 | |
| Amgen INC. | $58.42 | 2019 | |
| Abbvie INC. | $55.24 | 2021 | |
| Novo Nordisk INC | $54.91 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $35.49 | 2019 | |
| Astellas Pharma US INC | $28.58 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $25.03 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $18.38 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.92 | 2021 | |
| Allergan, INC. | $15.78 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.54 | 2019 | |
| Dexcom, INC. | $14.94 | 2022 | |
| Amarin Pharma, INC. | $13.52 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.24 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $12.03 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.13 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Astik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.